An Update on the Use of Immunomodulators in Primary Immunodeficiencies.


The genomic revolution in the past decade fuelled by breathtaking advances in sequencing technologies has defined several new genetic diseases of the immune system. Many of these newly characterized diseases are a result of defects in genes involved in immune regulation. The discovery of these diseases has opened a vista of new therapeutic possibilities… (More)
DOI: 10.1007/s12016-016-8591-2